Chapter 4 Role of Prolactin in Autoimmune Diseases

Handbook of Systemic Autoimmune Diseases

Volumn 9, Issue , 2008, Pages 29-43

  De Bellis, Annamaria ^a   Bizzarro, Antonio ^a   Bellastella, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649827836     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(07)00204-8     Document Type: Review

References (108)

1. Alvarez-Nemegyei J., Cobarrubias-Cobos A., Escalante-Triay F., Sosa-Munoz J., Miranda J.M., and Jara L.J. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 7 (1998) 414-419
2. Anaya J.M., and Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. Isr. Med. Assoc. J. 7 (2005) 740-741
3. Atwater I., Gondos B., Di Bartolomeo R., Bazaes R., and Jovanovic L. Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse. Ann. Clin. Lab. Sci. 32 (2002) 87-92
4. Azar S.T., and Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr. Res. 25 (1999) 207-214
5. Bazan J.F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 31 (1989) 788-795
6. Bellastella A., Bizzarro A., Coronella C., Bellastella G., Sinisi A.A., and De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease?. Eur. J. Endocrinol. 149 (2003) 363-376
7. Ben-Jonathan N., Mershon J., Allen D., and Steinmetz R. Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr. Rev. 17 (1996) 639-669
8. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17 (1996) 64-102
9. Betterle C., Volpato M., Greggio A.N., and Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J. Pediatr. Endocrinol. Metab. 9 Suppl. (1996) 113-123
10. Blanco-Favela F., Quintal-Alvarez G., and Leanos-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J. Rheumatol. 26 (1999) 55-59
11. Bole-Feysot C., Goffin V., Edery M., Binart N., and Kelly P.A. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19 (1998) 225-268
12. Bottazzo G.F., Pouplard A., Florin-Christensen A., and Doniach D. Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 2 (1975) 97-101
13. Bouchard B., Ormandy C.J., Di Santo J.P., and Kelly P.A. Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 15 (1999) 576-582
14. Buckley A.R. Prolactin, a lymphocyte growth and survival factor. Lupus 10 (2001) 684-690
15. Buskila D., Lorber M., Neumann L., Flusser D., and Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J. Rheumatol. 23 (1996) 629-632
16. Carrier M., Russell D.H., Wild J.C., Emery R.W., and Copeland J.G. Prolactin as a marker of rejection in human heart transplantation. J. Heart Transplant. 6 (1987) 290-292
17. Caturegli P., Newschaffer C., Olivi A., Pomper M.G., Burger P.C., and Rose N.R. Autoimmune hypophysitis. Endocr. Rev. 26 (2005) 599-614
18. Chikanza I.C. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann. NY Acad. Sci. 22 876 (1999) 119-130
19. Chikanza I.C., and Grossman A.B. Reciprocal interactions between the neuroendocrine and immune systems during inflammation. Rheum. Dis. Clin. North Am. 26 (2000) 693-711
20. Chuang E., and Molitch M.E. Prolactin and autoimmune diseases in humans. Acta Biomed. 78 (2007) 255-261
21. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 339 (1998) 285-291
22. Cruz J., Avina-Zubieta A., Martinez de la Escalera G., Clapp C., and Lavalle C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 1331-1335
23. De Bellis A., Bizzarro A., Pivonello R., Lombardi G., and Bellastella A. Prolactin and autoimmunity. Pituitary 8 (2005) 25-30
24. De Bellis, A., Colao, A., Pivonello, R., Savoia, A., Tirelli, G, Battaglia, M., Ruocco, G., Lombardi, G., Bellastella, A., Bizzarro, A. 2007. Antipituitary antibodies in idiopathic hyperprolactinemic patients. Ann. NY Acad. Sci. 1107, 129-135.
25. Dorshkind K., and Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21 (2000) 292-312
26. Dorshkind K., and Horseman N.D. Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23 (2001) 288-294
27. Esquifino A.I., Cano P., Zapata A., and Cardinali D.P. Experimental allergic encephalomyelitis in pituitary-grafted Lewis rats. J. Neuroinflammation 23 (2006) 3-20
28. Formby B. Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol. Metab. Clin. North. Am. 24 (1995) 187-205
29. Freemark M., Avril I., Fleenor D., Driscoll P., Petro A., Opara E., Kendall W., Oden J., Bridges S., Binart N., Breant B., and Kelly P.A. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143 (2002) 1378-1385
30. Gearing D.P., Druck T., Huebner K., Overhauser J., Gilbert D.J., Copeland N.G., and Jenkins N.A. The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5p12-p13. Genomics 18 (1993) 148-150
31. Gellersen B., Kempf R., Telgmann R., and Di Mattia G.E. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol. Endocrinol. 8 (1994) 356-373
32. Gerlo S., Verdood P., Hooghe-Peters E.L., and Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J. Neuroimmunol. 162 (2005) 190-193
33. Goffin V., Binart N., Touraine P., and Kelly P.A. Prolactin: the new biology of an old hormone. Annu. Rev. Physiol. 64 (2002) 47-67
34. Goh K.L., and Wang F. Thyroid disorders in systemic lupus erythematosus. Ann. Rheum. Dis. 45 (1986) 579-583
35. Gutierrez M.A., Molina J.F., Jara L.J., Cuellar M.L., Garcia C., Gutierrez-Urena S., Gharavi A., and Espinoza L.R. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 4 (1995) 348-352
36. Haga H.J., and Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome. J. Rheumatol. 26 (1999) 1291-1295
37. Harirchian M.H., Sahraian M.A., and Shirani A. Serum prolactin level in patients with multiple sclerosis: a case control study. Med. Sci. Monit. 12 (2006) CR177-CR180
38. Hartmann D.P., Holaday J.W., and Bernton E.W. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3 (1989) 2194-2202
39. Hawkins T.A., Gala R.R., and Dunbar J.C. Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 18 (1994) 155-162
40. Heesen C., Gold S.M., Bruhn M., Monch A., and Schulz K.H. Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?. Endocr. Res. 28 (2002) 9-18
41. Hooghe R., Martens N., and Hooghe-Peters. E.L. Prolactin and the immune system. In: Geenen V., and Chrousos G. (Eds). Immunoendocrinology in Health and Disease (2004), Marcel Dekker, New York 207-239
42. Horseman N.D. Prolactin receptor diversity in humans: novel isoforms suggest general principles. Trends Endocrinol. Metab. 13 (2002) 47-48
43. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., and Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16 (1997) 6926-6935
44. Ishibashi M., Kuzuya N., Sawada S., Kitamura K., Kamoi K., and Yamaji T. Anti-thyroid antibodies in patients with hyperprolactinemia. Endocrinol. Jpn. 38 (1991) 517-522
45. Jacobi A.M., Rohde W., Volk H.D., Dorner T., Burmester G.R., and Hiepe F. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann. Rheum. Dis. 60 (2001) 242-247
46. Jara L.J., Gomez-Sanchez C., Silveira L.H., Martinez-Osuna P., Vasey F.B., and Espinoza L.R. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am. J. Med. Sci. 303 (1992) 222-226
47. Jara L.J., Navarro C., Medina G., Vera-Lastra O., and Blanco F. Immune-neuroendocrine interactions and autoimmune diseases. Clin. Dev. Immunol. 13 (2006) 109-123
48. Jara L.J., Vera-Lastra O., Mirando J.M., Alcala M., and Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 10 (2001) 748-756
49. Jimena P., Aguirre M.A., Lopez-Curbelo A., de Andres M., Garcia-Courtay C., and Cuadrado M.J. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 7 (1998) 383-386
50. Kapur G., Patwari A.K., Narayan S., and Anand V.K. Serum prolactin in celiac disease. J. Trop. Pediatr. 50 (2004) 37-40
51. Kelley K.W., Weigent D.A., and Kooijman R. Protein hormones and immunity. Brain Behav. Immun. 21 (2007) 384-392
52. Khamashta M.A., Ruiz-Irastorza G., and Hughes G.R. Systemic lupus erythematosus flares during pregnancy. Rheum Dis. Clin. North Am. 23 (1997) 15-30
53. Kochendoerfer S.K., Krishnan N., Buckley D.J., and Buckley A.R. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J. Endocrinol. 178 (2003) 265-273
54. Kooijman R., Hooghe-Peters E.L., and Hooghe R. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv. Immunol. 63 (1996) 377-454
55. Kramer C.K., Tourinho T.F., de Castro W.P., and da Costa Oliveira M. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Arch. Med. Res. 36 (2005) 54-58
56. Krumenacker J.S., Buckley D.J., Leff M.A., McCormack J.T., de Jong G., Gout P.W., Reed J.C., Miyashita T., Magnuson N.S., and Buckley A.R. Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine 9 (1998) 163-170
57. Kullich W.C., and Klein G. High levels of macrophage inflammatory protein-1alpha correlate with prolactin in female patients with active rheumatoid arthritis. Clin. Rheumatol. 17 (1998) 263-264
58. Lahat N., Miller A., Shtiller R., and Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J. Neuroimmunol. 47 (1993) 35-40
59. La Montagna G., Baruffo A., Pasquali D., Bellastella A., Tirri G., and Sinisi A.A. Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis. Rheumatology 40 (2001) 310-314
60. Larrea F., Martinez-Castillo A., Cabrera V., Alcocer-Varela J., Queipo G., Carino C., and Alarcon-Segovia D. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J. Clin. Endocrinol. Metab. 82 (1997) 3664-3669
61. La Voie H.A., and Witorsch R.J. Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells. Proc. Soc. Exp. Biol. Med. 209 (1995) 257-269
62. Leanos A., Pascoe D., Fraga A., and Blanco-Favela F. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 7 (1998) 398-403
63. Leanos-Miranda A., Pascoe-Lira D., Chavez-Rueda K.A., and Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J. Rheumatol. 28 (2001) 1546-1553
64. Leanos-Miranda A., Pascoe-Lira D., Chavez-Rueda K.A., and Blanco-Favela F. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus. J. Clin. Endocrinol. Metab. 86 (2001) 2619-2624
65. Legakis I., Petroyianni V., Saramantis A., and Tolis G. Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis. Horm. Metab. Res. 33 (2001) 585-589
66. Lever E.G., and McKerron C.G. Auto-immune Addison's disease associated with hyperprolactinaemia. Clin. Endocrinol. (Oxf) 21 (1984) 451-457
67. Li M., Kaiser H.D., and Peeva E. Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?. Clin. Rheumatol. 25 (2006) 602-605
68. Li-Yuan Y.L. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 57 (2002) 435-455
69. Matera L. Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation 4 (1997) 171-180
70. Matera L., Galetto A., Geuna M., Vekemans K., Ricotti E., Contarini M., Moro F., and Basso G. Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology 100 (2000) 29-36
71. Matera L., and Mori M. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann. N. Y. Acad. Sci. 917 (2000) 505-513
72. Matera L., Mori M., and Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 10 (2001) 728-734
73. Matera L., Mori M., Geuna M., Buttiglieri S., and Palestro G. Prolactin in autoimmunity and antitumor defence. J. Neuroimmunol. 109 (2000) 47-55
74. Matera L., and Rapaport R. Growth and lactogenic hormones. Neuroimmune Biol. 2 (2002) 1-306
75. McMurray R., Keisler D., Izui S., and Walker S.E. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin. Immunol. Immunopathol. 71 (1994) 338-343
76. McMurray R.W. Bromocriptine in rheumatic and autoimmune diseases. Semin. Arthritis Rheum. 31 (2001) 21-32
77. McMurray R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. Int. Immunopharmacol. 1 (2001) 995-1008
78. Mellai M., Giordano M., D'Alfonso S., Marchini M., Scorza R., Giovanna Danieli M., Leone M., Ferro I., Liguori M., Trojano M., Ballerini C., Massacesi L., Cannoni S., Bomprezzi R., and Momigliano-Richiardi P. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum. Immunol. 64 (2003) 274-284
79. Mendez I., Alcocer-Varela J., Parra A., Lava-Zavala A., de la Cruz D.A., Alarcon-Segovia D., and Larrea F. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus 13 (2004) 45-53
80. Morales P., Carretero M.V., Geronimo H., Copin S.G., Gaspar M.L., Marcos M.A., and Martin-Perez J. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ. 10 (1999) 583-590
81. Nagafuchi H., Suzuki N., Kaneko A., Asai T., and Sakane T. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 26 (1999) 1890-1900
82. Nelson J.L., and Ostensen M. Pregnancy and rheumatoid arthritis. Rheum. Dis. Clin. North Am. 23 (1997) 195-212
83. Nithya K., and Buckley A.R. Common signaling in the neuroendocrine and immune system. In: Geenen V., and Chrousos G. (Eds). Immunoendocrinology in Health and Disease (2004), Marcel Dekker, New York 21-50
84. Notsu K., Ito Y., Furuya H., Ohguni S., and Kato Y. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis. Endocr. J. 44 (1997) 89-94
85. Pacilio M., Migliaresi S., Meli R., Ambrosone L., Bigliardo B., and Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus-association with disease activity. J. Rheumatol. 28 (2001) 2216-2221
86. Peeva E., Venkatesh J., Michael D., and Diamond B. Prolactin as a modulator of B cell function: implications for SLE. Biomed. Pharmacother. 58 (2004) 310-319
87. Pellegrini I., Lebrun J.J., Ali S., and Kelly P.A. Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6 (1992) 1023-1031
88. Ram S., Blumberg D., Newton P., Anderson N.R., and Gama R. Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact?. Rheumatology 43 (2004) 1272-1274
89. Reichlin S. Neuroendocrinology. In: Wilson J.D., and Foster D.W. (Eds). Williams Textbook of Endocrinology. 8th ed (1992), WB Saunders, Philadelphia 135-219
90. Reuman P.D. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum. 50 November (2004) 3616-3618
91. Rezaieyazdi Z., and Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol. Int. 26 (2006) 1036-1039
92. Richards S.M., and Murphy W.J. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. J. Neuroimmunol. 109 (2000) 56-62
93. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
94. Sarkar C., Das S., Chakroborty D., Chowdhury U.R., Basu B., Dasgupta P.S., and Basu S. Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J. Immunol. 177 (2006) 7525-7529
95. Selye H. A syndrome produced by diverse nocuous agents. J. Neuropsychiatry Clin. Neurosci. 10 (1998) 230-231
96. Stevens A., Ray D., Alansari A., Hajeer A., Thomson W., Donn R., Ollier W.E., Worthington J., and Davis J.R. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 2358-2366
97. Stevens A., Ray D.W., Worthington J., and Davis J.R. Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10 (2001) 676-683
98. Thodou E., Asa S.L., Kontogeorgos G., Kovacs K., Horvath E., and Ezzat S. Lymphocytic hypohysitis: clinicopathological findings. J. Clin. Endocrinol. Metab. 80 (1995) 2302-2311
99. Vera-Lastra O., Jara L.J., and Espinoza L.R. Prolactin and autoimmunity. Autoimmun. Rev. 1 (2002) 360-364
100. Vera-Lastra O., Jara L.J., Medina G., Rojas J.L., Velaquez F., Ariza R., Normandia A., and Fuentes M. Functional hyperprolactinemia and hypophyseal microadenoma in systemic sclerosis. J. Rheumatol. 33 (2006) 1108-1112
101. Vera-Lastra O., Mendez C., Jara L.J., Cisneros M., Medina G., Ariza R., and Espinoza L.R. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J. Rheumatol. 30 (2003) 2140-2146
102. Walker S.E. Treatment of systemic lupus erythematosus with bromocriptine. Lupus 10 (2001) 197-202
103. Walker S.E. Impaired hypothalamic function, prolactinomas, and autoimmune diseases. J. Rheumatol. 33 (2006) 1036-1037
104. Walker S.E., Allen S.H., Hoffman R.W., and McMurray R.W. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 4 (1995) 3-9
105. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann. Neurol. 36 (1994) 47-53
106. Yamasaki K., Horiuchi I., Minohara M., Osoegawa M., Kawano Y., Ohyagi Y., Yamada T., and Kira J. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern. Med. 39 (2000) 296-299
107. You X., Teng W., and Shan Z. Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha. Chin. Med. J. 112 (1999) 61-66
108. Zoumakis E., Chrousos G.P., and Elenkov J. Hypothalamic-pituitary-adrenal axis. Effect on innate and adaptive immunity. In: Geenen V., and Chrousos G. (Eds). Immunoendocrinology in Health and Disease (2004), Marcel Dekker, New York 51-63